SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-032875
Filing Date
2022-02-09
Accepted
2022-02-09 17:21:08
Documents
19
Period of Report
2022-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d484151d8k.htm   iXBRL 8-K 38852
2 EX-1.1 d484151dex11.htm EX-1.1 224865
3 EX-4.1 d484151dex41.htm EX-4.1 113976
4 EX-5.1 d484151dex51.htm EX-5.1 18884
5 EX-10.1 d484151dex101.htm EX-10.1 97683
6 EX-10.2 d484151dex102.htm EX-10.2 13444
10 GRAPHIC g484151dsp77.jpg GRAPHIC 4468
11 GRAPHIC g484151g0209152245548.jpg GRAPHIC 1843
  Complete submission text file 0001193125-22-032875.txt   771764

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA zsan-20220208.xsd EX-101.SCH 2872
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20220208_lab.xml EX-101.LAB 17236
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20220208_pre.xml EX-101.PRE 10823
13 EXTRACTED XBRL INSTANCE DOCUMENT d484151d8k_htm.xml XML 3264
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 22608310
SIC: 2834 Pharmaceutical Preparations